Edward H. Nash

EDWARD H. NASH joined Legg Mason’s Equity Research Department as a
Principal in March 2003, focusing on the biotechnology/life sciences
sector. Most recently, Mr. Nash was a senior analyst in equity research
covering the biotechnology sector at Rodman & Renshaw, Inc. He has also
been affiliated with Ladenburg Thalmann & Co., Commerce Capital Markets,
Inc. as well as Lazard Freres, LLC in their equity research departments,
also focusing on biotechnology. Mr. Nash began his Wall Street career as
a healthcare analyst at SG Cowen Asset Management, Inc. Early in his
career, Mr. Nash was a basic science researcher with The Center for
Macromolecular Crystallography in Birmingham, AL, working in rational
drug design. Concurrently, Mr. Nash was working in basic research in the
field of evolutionary biochemistry. Mr. Nash graduated from Spring Hill
College, Mobile, AL, with a BS in biology and chemistry. He also has an
MPH in epidemiology from The University of Alabama at Birmingham. Mr.
Nash has both an MBA in Finance and an MS in International Business from
The University of Miami.